AEON Biopharma (AEON) vs Lipocine (LPCN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Lipocine (LPCN) has outperformed AEON Biopharma (AEON) over the past year, losing 31.7% versus a loss of 66.7%. Lipocine is the larger company by market cap ($16.0 million vs $14.9 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AEON | LPCN |
|---|---|---|
| Share price | $0.2992 | $1.94 |
| Market cap | $14.92M | $15.99M |
| 1-day change | -3.86% | -11.81% |
| YTD return | -71.70% | -72.60% |
| 1-year return | -66.71% | -31.68% |
| 5-year return | — | -88.55% |
| EPS (TTM) | $-4.39 | $-1.85 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.45 | $12.37 |
| 52-week low | $0.177 | $1.81 |
| Distance from 52-week high | -79.37% | -84.32% |
| Average volume | 8.58M | 1.68M |
| Shares outstanding | 49.88M | 8.24M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- LPCN has outperformed AEON by 35.0 percentage points over the past year.
AEON vs LPCN FAQ
Which is bigger, AEON Biopharma or Lipocine?
Lipocine (LPCN) is larger, with a market capitalization of $15.99M compared with $14.92M for AEON Biopharma (AEON).
Which stock has performed better over the past year, AEON or LPCN?
LPCN returned -31.68% over the past 12 months, compared with -66.71% for AEON (price return, excluding dividends). Past performance does not predict future results.
Are AEON Biopharma and Lipocine in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.